Scavenger receptor class B, type I: a promising immunotherapy target

Immunotherapy. 2011 Mar;3(3):395-406. doi: 10.2217/imt.10.104.

Abstract

Scavenger receptor class B, type I (SR-BI) is a crucial molecule in lipid metabolism, since the interaction of high-density lipoproteins (HDLs) with SR-BI is involved in reverse cholesterol transport and cholesterol efflux. Recent findings also underscore a critical role of SR-BI in antimicrobial and immune responses. SR-BI is not only highly expressed in liver and steroidogenic glands, but also in endothelial cells, macrophages and dendritic cells. SR-BI mainly mediates anti-inflammatory responses, which may be altered by dysfunctional HDLs produced in several diseases. Moreover, SR-BI has been involved in the capture and cross-presentation of antigens from viruses, bacteria and parasites. It thus works as a pattern-recognition receptor that interacts with both damage-associated molecular patterns and pathogen-associated molecular patterns. These new findings in the microbiology and immunology fields present SR-BI as an unexplored therapeutic target that warrants further basic and applied research.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antigen Presentation / immunology
  • Biological Transport
  • CD36 Antigens* / chemistry
  • CD36 Antigens* / immunology
  • CD36 Antigens* / metabolism
  • Cholesterol / metabolism
  • Cross-Priming / immunology
  • Humans
  • Immunity / physiology*
  • Immunotherapy
  • Inflammation / immunology*
  • Lipoproteins, HDL / metabolism
  • Mice
  • Signal Transduction
  • Toll-Like Receptors / metabolism

Substances

  • CD36 Antigens
  • Lipoproteins, HDL
  • Toll-Like Receptors
  • Cholesterol